Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Table 1 Etiology and classification of thrombotic microangiopathies
Primary TMAs | |
Shiga toxin-producing E. Coli-associated HUS | |
Thrombotic thrombocytopenic purpura | |
Atypical HUS or complement-mediated | |
Secondary TMAs | |
Infections including viral, fungal, and bacterial | |
Drugs including immunosuppressants and chemotherapeutic agents | |
Autoimmune diseases | |
Malignant hypertension | |
Malignancy | |
Metabolic defects | |
Pregnancy | |
Transplantation, both hematopoietic stem cell transplantation and solid organ transplantation | |
Disseminated intravascular coagulation | |
Radiation |
- Citation: Mubarak M, Raza A, Rashid R, Sapna F, Shakeel S. Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra. World J Transplant 2024; 14(1): 90277
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/90277.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.90277